RAGHAVENDRA SIRAGAVARAPU: Open Payments
NPI 1154582377 · CHERRY HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 56 payments from 16 companies in 2025. Trend: 2023 $45 · 2024 $593 · 2025 $1,043
Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $163 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $148 |
| ABBVIE INC. | 10 | $139 |
| Vertical Pharmaceuticals, LLC | 4 | $101 |
| Corium, LLC | 5 | $81 |
| Supernus Pharmaceuticals, Inc. | 5 | $79 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Neos Therapeutics, LP | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 3 | $46 |
Products named: COBENFY, CAPLYTA, VRAYLAR, Relexxii, Azstarys, Qelbree, REXULTI, SPRAVATO.
Industry payments across NJ — which companies pay providers there.
